000 01605 a2200409 4500
005 20250517071730.0
264 0 _c20161213
008 201612s 0 0 eng d
022 _a1879-0720
024 7 _a10.1016/j.ejps.2015.12.020
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKravljaca, Milica
245 0 0 _aThe importance of MDR1 gene polymorphisms for tacrolimus dosage.
_h[electronic resource]
260 _bEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
_cFeb 2016
300 _a109-13 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aATP Binding Cassette Transporter, Subfamily B
_xgenetics
650 0 4 _aAdult
650 0 4 _aCytochrome P-450 CYP3A
_xgenetics
650 0 4 _aFemale
650 0 4 _aHaplotypes
650 0 4 _aHumans
650 0 4 _aImmunosuppressive Agents
_xadministration & dosage
650 0 4 _aKidney Transplantation
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPolymorphism, Single Nucleotide
650 0 4 _aTacrolimus
_xadministration & dosage
700 1 _aPerovic, Vladimir
700 1 _aPravica, Vera
700 1 _aBrkovic, Voin
700 1 _aMilinkovic, Marija
700 1 _aLausevic, Mirjana
700 1 _aNaumovic, Radomir
773 0 _tEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
_gvol. 83
_gp. 109-13
856 4 0 _uhttps://doi.org/10.1016/j.ejps.2015.12.020
_zAvailable from publisher's website
999 _c25577082
_d25577082